RNA Interference (RNAi) technology has rapidly become one of the key methods used in functional genomics. RNAi is used to block the expression of genes and create phenotypes that can potentially yield clues about the function of these genes. In the postgenomic era, the elucidation of the physiologic
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development
β Scribed by Paul H. Johnson, John J. Rossi
- Publisher
- Wiley
- Year
- 2011
- Tongue
- English
- Leaves
- 323
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
β¦ Table of Contents
fmatter.pdf......Page 1
ins.pdf......Page 13
ch1.pdf......Page 17
ch2.pdf......Page 27
ch3.pdf......Page 65
ch4.pdf......Page 91
ch5.pdf......Page 138
ch6.pdf......Page 188
ch7.pdf......Page 230
ch8.pdf......Page 286
index.pdf......Page 320
π SIMILAR VOLUMES
RNA Interference (RNAi) technology has rapidly become one of the key methods used in functional genomics. RNAi is used to block the expression of genes and create phenotypes that can potentially yield clues about the function of these genes. In the postgenomic era, the elucidation of the physiologic
With its focus on industrial pharmaceutical research, written by international experts from the industry, this book fills in a gap in the existing literature. It reflects the combination of such pharmaceutical interests as drug delivery, drug targeting, quality and safety management, drug approval a
Specialists in pharmaceutical biotechnology from the US, Germany, South Africa, and Ireland introduce the concepts and technologies of the field, then examine industrial development and the production process, special pharmaceutical aspects of therapeutic proteins, and prospects for the industry int
2nd Edition. β Wiley, 2012. β 658 p.<div class="bb-sep"></div>This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmace